The basis of allotment for Indiqube Spaces IPO will be out today, July 28, 2025. The bidding window was open from July 23, 2025, to July 25, 2025, during which the IPO received 21,27,45,960 bids against 1,71,48,335 total shares offered.
Indiqube Spaces IPO is a bookbuilding issue of ₹700 crores, consisting of a fresh issue of ₹650 crores and an offer for sale of ₹50 crores. The price band is set between ₹225 and ₹237 per share.
ICICI Securities Limited and JM Financial Limited are the book-running lead managers, while MUFG Intime India Private Limited is the registrar for the Indiqube Spaces IPO.
[25 July, 2025, End of the day]
Investor Category |
Subscription (Times) |
Qualified Institutional Buyers (QIBs) |
14.35 |
Non-Institutional Investors |
8.27 |
Retail Individual Investors (RIIs) |
12.90 |
Employees |
6.83 |
Total |
12.41 |
Click here to explore other Upcoming IPOs
The net proceeds from the fresh issue will be used towards:
Click here to check out newly Listed IPOs
As of 28 July 2025, Indiqube Spaces IPO GMP stood at ₹5. The estimated listing price is ₹242, i.e., a 2.11% gain per share over the upper price band.
Source: Business Standard Report dated 28 July, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Founded in 2015 and headquartered in Bengaluru, Indiqube Spaces is a managed workplace solutions company that offers customised workspace solutions to businesses of all sizes, from startups and growing enterprises to large corporates. As of March 31, 2025, the company manages a portfolio of 115 centers across 15 cities, consisting of 105 operational centres and 10 centres.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here